| Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults H Lal, AL Cunningham, O Godeaux, R Chlibek, J Diez-Domingo, ... New England Journal of Medicine 372 (22), 2087-2096, 2015 | 1373 | 2015 |
| Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older AL Cunningham, H Lal, M Kovac, R Chlibek, SJ Hwang, J Díez-Domingo, ... New England Journal of Medicine 375 (11), 1019-1032, 2016 | 1012 | 2016 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a … Y Li, X Wang, DM Blau, MT Caballero, DR Feikin, CJ Gill, SA Madhi, ... The Lancet 399 (10340), 2047-2064, 2022 | 693 | 2022 |
| Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization … N Gossger, MD Snape, LM Yu, A Finn, G Bona, S Esposito, N Principi, ... Jama 307 (6), 573-582, 2012 | 366 | 2012 |
| Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study X Wang, Y Li, KL O'brien, SA Madhi, MA Widdowson, P Byass, SB Omer, ... The Lancet Global Health 8 (4), e497-e510, 2020 | 323 | 2020 |
| Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? S Esposito, R Cohen, JD Domingo, OF Pecurariu, D Greenberg, ... The Pediatric infectious disease journal 31 (6), e78-85, 2012 | 165 | 2012 |
| Antibiotic use in children–a cross-national analysis of 6 countries I Youngster, J Avorn, V Belleudi, A Cantarutti, J Díez-Domingo, ... The Journal of pediatrics 182, 239-244. e1, 2017 | 139 | 2017 |
| A randomized, double-blind, phase III study of the immunogenicity and safety of a 9-valent human papillomavirus L1 virus-like particle vaccine (V503) versus Gardasil® in 9–15 … T Vesikari, N Brodszki, P van Damme, J Diez-Domingo, G Icardi, ... The Pediatric infectious disease journal 34 (9), 992-998, 2015 | 139 | 2015 |
| Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly J Puig-Barberà, J Díez-Domingo, ÁB Varea, GS Chavarri, JAL Rodrigo, ... Vaccine 25 (42), 7313-7321, 2007 | 128 | 2007 |
| A cost benefit analysis of routine varicella vaccination in Spain JD Domingo, M Ridao, J Latour, A Ballester, A Morant Vaccine 17 (11-12), 1306-1311, 1999 | 128 | 1999 |
| Social, economic, and health impact of the respiratory syncytial virus: a systematic search J Díez-Domingo, EG Pérez-Yarza, JA Melero, M Sánchez-Luna, ... BMC infectious diseases 14, 1-14, 2014 | 120 | 2014 |
| International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines CN Dodd, SA Romio, S Black, C Vellozzi, N Andrews, M Sturkenboom, ... Vaccine 31 (40), 4448-4458, 2013 | 112 | 2013 |
| Population-based analysis of bronchiolitis epidemiology in Valencia, Spain C Muñoz-Quiles, M López-Lacort, I Úbeda-Sansano, S Alemán-Sánchez, ... The Pediatric infectious disease journal 35 (3), 275-280, 2016 | 85 | 2016 |
| Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age J Puig-Barberà, J Diez-Domingo, SP Hoyos, AB Varea, DG Vidal Vaccine 23 (3), 283-289, 2004 | 85 | 2004 |
| Immunogenicity and safety of three doses of a bivalent (B: 4: p1. 19, 15 and B: 4: p1. 7-2, 4) meningococcal outer membrane vesicle vaccine in healthy adolescents D Boutriau, J Poolman, R Borrow, J Findlow, JD Domingo, J Puig-Barbera, ... Clinical and Vaccine Immunology 14 (1), 65-73, 2007 | 81 | 2007 |
| The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE … C Boutry, A Hastie, J Diez-Domingo, JC Tinoco, CJ Yu, C Andrews, ... Clinical Infectious Diseases 74 (8), 1459-1467, 2022 | 76 | 2022 |
| Meningococcal serogroup B bivalent rLP2086 vaccine elicits broad and robust serum bactericidal responses in healthy adolescents T Vesikari, L Østergaard, J Diez-Domingo, J Wysocki, CE Flodmark, ... Journal of the Pediatric Infectious Diseases Society 5 (2), 152-160, 2016 | 76 | 2016 |
| Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines–Multi-country assessment D Weibel, M Sturkenboom, S Black, M de Ridder, C Dodd, J Bonhoeffer, ... Vaccine 36 (41), 6202-6211, 2018 | 75 | 2018 |
| Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain A Orrico-Sánchez, M López-Lacort, C Muñoz-Quiles, G Sanfélix-Gimeno, ... BMC psychiatry 20, 1-9, 2020 | 74 | 2020 |
| Can COVID-19 increase the risk of herpes zoster? A narrative review J Diez-Domingo, R Parikh, AB Bhavsar, E Cisneros, N McCormick, ... Dermatology and Therapy 11 (4), 1119-1126, 2021 | 71 | 2021 |
Miguel Ángel Martínez BeneitoUniversidad de Valencia在 uv.es 的电子邮件经过验证
